Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 7/20 | 0.38 |
| ▸ | BRD4 | O60885 | 5/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.34 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29936288 | 0.88 | MAPK14 (0.37) | MAPK14BRD4PRKCAGSK3BGAA | |
| SCHEMBL27093101 | 0.87 | PDE2A (0.39) | MAPK14BRD4PRKCAGSK3BAKR1A1 | |
| SCHEMBL27094647 | 0.79 | PDE2A (0.40) | MAPK14BRD4PRKCAGSK3BAKR1A1 | |
| SCHEMBL17535882 | 0.78 | AMY1A (0.46) | MAPK14GAAMAPTL3MBTL1AKR1A1 | |
| SCHEMBL29935986 | 0.77 | MAPK14 (0.40) | MAPK14BRD4PRKCAGSK3BAKR1A1 | |
| SCHEMBL29936217 | 0.74 | MAPK14 (0.38) | MAPK14BRD4 | |
| SCHEMBL29935906 | 0.72 | MAPK14 (0.39) | MAPK14BRD4GAAMAPT | |
| SCHEMBL30708902 | 0.72 | MAPK14 (0.38) | MAPK14BRD4PRKCAGSK3BAKR1A1 | |
| SCHEMBL29936000 | 0.72 | MAPK14 (0.39) | MAPK14BRD4 | |
| SCHEMBL27093099 | 0.71 | MAPK14 (0.39) | MAPK14BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240215577-A1 | FUNGICIDAL PYRIDONES | FMC CORPORATION | 2024-07-04 | — | — | US | claimed |
| EP-4323342-A1 | FUNGICIDAL PYRIDONES | FMC CORPORATION (US) | 2024-02-21 | — | — | EP | claimed |
| CN-117203188-A | Fungicidal pyridones | FMC公司 | 2023-12-08 | — | — | CN | claimed |
| WO-2022221165-A1 | FUNGICIDAL PYRIDONES | FMC CORPORATION (US) | 2022-10-20 | — | — | WO | claimed |
| US-20240215577-A1 | FUNGICIDAL PYRIDONES | FMC CORPORATION | 2024-07-04 | — | — | US | disclosed |
| EP-4323342-A1 | FUNGICIDAL PYRIDONES | FMC CORPORATION (US) | 2024-02-21 | — | — | EP | disclosed |
| CN-117203188-A | Fungicidal pyridones | FMC公司 | 2023-12-08 | — | — | CN | disclosed |
| WO-2022221165-A1 | FUNGICIDAL PYRIDONES | FMC CORPORATION (US) | 2022-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240215577-A1 | FUNGICIDAL PYRIDONES | PNPO, CYP1B1, CYP1A1 | MAPK14 2415/4885BRD4 2827/4885PRKCA 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.